Used in immunological research to quantify C3a, a key biomarker of complement system activation. Helps assess inflammatory responses in diseases such as sepsis, autoimmune disorders, and ischemia-reperfusion injury. Enables monitoring of complement activation in clinical samples like plasma and serum, supporting studies on therapeutic interventions targeting the complement pathway. Widely applied in biomedical research and drug development for inflammation-related conditions.